The store will not work correctly when cookies are disabled.
3-(3,5-dichlorostyryl)-2-phenylquinazolin-4(3H)-one
ID: ALA5280775
Max Phase: Preclinical
Molecular Formula: C22H14Cl2N2O
Molecular Weight: 393.27
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=c1c2ccccc2nc(-c2ccccc2)n1/C=C/c1cc(Cl)cc(Cl)c1
Standard InChI: InChI=1S/C22H14Cl2N2O/c23-17-12-15(13-18(24)14-17)10-11-26-21(16-6-2-1-3-7-16)25-20-9-5-4-8-19(20)22(26)27/h1-14H/b11-10+
Standard InChI Key: PQVUNPRBAAIIPH-ZHACJKMWSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
-3.5559 -0.0003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5559 -0.8253 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8426 -1.2317 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1355 -0.8216 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1355 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8443 0.4102 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4258 0.4091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7121 -0.0015 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.7121 -0.8190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4207 -1.2340 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.0005 -1.2299 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7112 -0.8192 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4203 -1.2295 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4203 -2.0515 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7130 -2.4617 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0005 -2.0551 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0023 0.4093 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7092 -0.0015 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4209 0.4093 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4209 1.2310 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1309 1.6399 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8443 1.2290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8443 0.4113 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1355 -0.0033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5559 0.0005 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
2.1309 2.4617 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-1.4258 1.2308 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
6 1 2 0
5 7 1 0
8 7 1 0
9 8 1 0
10 9 2 0
4 10 1 0
9 11 1 0
12 11 2 0
13 12 1 0
14 13 2 0
15 14 1 0
16 15 2 0
11 16 1 0
8 17 1 0
17 18 2 0
18 19 1 0
20 19 2 0
21 20 1 0
22 21 2 0
23 22 1 0
24 23 2 0
19 24 1 0
23 25 1 0
21 26 1 0
7 27 2 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 393.27 | Molecular Weight (Monoisotopic): 392.0483 | AlogP: 6.00 | #Rotatable Bonds: 3 |
Polar Surface Area: 34.89 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: 1 | HBA (Lipinski): 3 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: 3.74 | CX LogP: 6.17 | CX LogD: 6.17 |
Aromatic Rings: 4 | Heavy Atoms: 27 | QED Weighted: 0.43 | Np Likeness Score: -0.67 |
References
1. Alagarsamy V, Chitra K, Saravanan G, Solomon VR, Sulthana MT, Narendhar B.. (2018) An overview of quinazolines: Pharmacological significance and recent developments., 151 [PMID:29656203] [10.1016/j.ejmech.2018.03.076] |